Ftse Mib
33.220,31
-0,29%
DAX
18.067,91
-0,31%
S&P 500
5.487,03
0,25%
NASDAQ
17.862,23
0,03%
Bitcoin
65.068,23
0,16%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Outlook Therapeutics Inc (OTLK) Outlook Therapeutics Inc (OTLK) Notizie

Outlook Therapeutics Inc

OTLK
7,31
-0,25 (-3,31%)
19 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
14/6/202422:10EDGAR2Form PRE 14A - Other preliminary proxy statements
11/6/202415:05GLOBEOutlook Therapeutics® to Present at the Virtual Investor..
28/5/202414:05GLOBEOutlook Therapeutics® Receives European Commission Marketing..
15/5/202423:19EDGAR2Form 8-K - Current report
15/5/202423:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/5/202423:00GLOBEOutlook Therapeutics® Reports Financial Results for Second..
13/5/202422:05EDGAR2Form 8-K - Current report
13/5/202414:50GLOBEOutlook Therapeutics® Announces UK Submission of Marketing..
09/5/202414:45GLOBEOutlook Therapeutics® to Report Financial Results for Second..
07/5/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
06/5/202422:09EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
02/5/202415:05GLOBEOutlook Therapeutics® to Present at the Retina World..
29/4/202415:00GLOBEOutlook Therapeutics® to Present at the Ophthalmology..
15/4/202422:15GLOBEOutlook Therapeutics® Announces Closing of Private Placement..
22/3/202412:35GLOBEOutlook Therapeutics® Receives European Union Positive CHMP..
18/3/202422:10GLOBEOutlook Therapeutics® Announces Closing of Private Placement..
12/3/202413:05GLOBEOutlook Therapeutics® Announces Effective Date for 1-for-20..
11/3/202421:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202422:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202422:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:16EDGAR2Form 8-K - Current report
14/2/202423:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/2/202422:40EDGAR2Form 8-K - Current report
14/2/202414:05GLOBEOutlook Therapeutics® Reports Financial Results for First..
08/2/202412:59EDGAR2Form DEF 14A - Other definitive proxy statements
31/1/202422:01EDGAR2Form SC 13D/A - General statement of acquisition of..
31/1/202414:05GLOBEOutlook Therapeutics® Doses First Subject in NORSE EIGHT
29/1/202423:00EDGAR2Form PRE 14A - Other preliminary proxy statements
24/1/202423:00EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
24/1/202412:02EDGAR2Form 8-K - Current report
23/1/202414:00GLOBEOutlook Therapeutics® Receives FDA Agreement Under Special..
22/12/202323:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22/12/202322:15EDGAR2Form 8-K - Current report
22/12/202314:05GLOBEOutlook Therapeutics® Reports Financial Results for Fiscal..
19/12/202314:05GLOBEOutlook Therapeutics® Submits Special Protocol Assessment..
18/12/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
06/12/202323:00EDGAR2Form 8-K - Current report
06/12/202314:05GLOBEOutlook Therapeutics® Announces Strategic Organizational..
04/12/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
29/11/202322:01EDGAR2Form SC 13D/A - General statement of acquisition of..
28/11/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
27/11/202314:05GLOBEOutlook Therapeutics® Announces Receipt of Type A Meeting..
21/11/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
14/11/202314:05GLOBEOutlook Therapeutics® Adds Global Commercial Expertise with..
14/11/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
02/11/202313:12EDGAR2Form 8-K - Current report
02/11/202313:05GLOBEOutlook Therapeutics® Provides Update on Type A Meetings..
01/11/202313:05GLOBEOutlook Therapeutics® to Present at Guggenheim’s 5th Annual..
Apertura: 7,58 Min: 7,054 Max: 7,84
Chiusura: 7,56

La tua Cronologia

NASDAQ
OTLK
Outlook Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network